On April 19, Yuanxin Technology, a comprehensive medical service platform, submitted an updated prospectus to the Hong Kong Stock Exchange. The updated prospectus shows that from 2019 to 2021, the total revenue of Yuanxin Technology was 2.352 billion yuan, 3.629 billion yuan and 5.938 billion yuan respectively, with a compound annual growth rate of 58.9% … As of December 31, 2021, comprehensive patients outside the hospital The service business revenue is 5.615 billion yuan, accounting for 94.6% of the total revenue in 2021; the two business segments of supply-side empowerment services and innovative medical and health services are growing rapidly, with revenue of 47 million yuan and 276 million yuan respectively, accounting for 2021. 0.8% and 4.6% of the total revenue, the year-on-year growth was 1143.2% and 211.9% respectively.
media coverage
Sohu Sohu Yiou
event tracking
- 2022-04-19Yuanxin Technology updates its prospectus and continues to promote its listing in Hong Kong
- 2021-10-18Yuanxin Technology plans to go public in Hong Kong, the cumulative loss exceeds 1 billion, and the gross profit margin of the main business declines
- 2021-08-04Yuanxin Technology Group completed the F round of financing of over 1.5 billion yuan
- 2021-02-09Yuanxin Technology completes 3 billion yuan in Series E financing
This article is reprinted from: https://readhub.cn/topic/8fjeLN97XbS
This site is for inclusion only, and the copyright belongs to the original author.